MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
REGENERON PHARMACEUTICALS, INC.

Regeneron Pharmaceuticals, Inc.

XNAS: REGN

Await Turnaround

Download real time

784.85 -4.60 (-0.58%)

45.07% Gain from 52W Low

2.5M

XNAS Volume

High volume today

XNAS 18 Sep, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Regeneron Pharma is on 23 Sep 2026 for the purpose of Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum See details

Regeneron Pharma - REGN - stock price prediction, stock price target, analyst ratings from 28 analysts

Regeneron Pharma has a share price target of US$ 849, revenue growth forecast of 18.0%, and profit growth estimate of 6.0% for FY26, based on top 28 analyst calls.

45.07% Gain from 52W Low

High volume today

Regeneron Pharma - REGN - stock price prediction, stock price target, analyst ratings from 28 analysts

Regeneron Pharma has a share price target of US$ 849, revenue growth forecast of 18.0%, and profit growth estimate of 6.0% for FY26, based on top 28 analyst calls.

Forecaster Screeners